Nexstim

Helsinki, Finland Founded: 2000 • Age: 26 yrs
Noninvasive brain stimulation is provided for stroke patient rehabilitation.
Request Access

About Nexstim

Nexstim is a company based in Helsinki (Finland) founded in 2000.. Nexstim has raised $29.67 million across 7 funding rounds from investors including Kreos Capital, Life Sciences Partners and Capricorn Partners. The company has 40 employees as of December 31, 2024. Nexstim offers products and services including SmartFocus TMS, NBS System 5, and NBS System 6. Nexstim operates in a competitive market with competitors including Blackrock Neurotech, MindMaze, INBRAIN Neuroelectronics, Precision Neuroscience and Synergia Medical, among others.

  • Headquarter Helsinki, Finland
  • Employees 40 as on 31 Dec, 2024
  • Stage Public
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Nexstim Plc
Operational Areas
Healthcare → Healthcare Products & Supplies
Key Metrics
  • Annual Revenue
    $9.08 M (USD)
    20.55
    as on Dec 31, 2024
  • Net Profit
    $-927 K (USD)
    32.79
    as on Dec 31, 2024
  • EBITDA
    $-383.09 K (USD)
    61.65
    as on Dec 31, 2024
  • Total Equity Funding
    $29.67 M (USD)

    in 7 rounds

  • Latest Funding Round
    $1.22 M (USD), Debt – Conventional

    Jan 23, 2018

  • Investors
  • Employee Count
    40

    as on Dec 31, 2024

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

IPO & Listings of Nexstim

Nexstim is a publicly listed company on the OMXHEX with ticker symbol NXTMH in Finland, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.

Exchange: OMXHEX · Ticker: NXTMH . Sector: Health technology · Finland

Products & Services of Nexstim

Nexstim offers a comprehensive portfolio of products and services, including SmartFocus TMS, NBS System 5, and NBS System 6. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Provides accurate brain targeting for neurosurgery and depression.

Offers navigated stimulation for neurological treatments.

Delivers precise TMS for radiotherapy and pain relief.

People of Nexstim
Headcount 10-50
Employee Profiles 16
Board Members and Advisors 4
Employee Profiles
People
Henri Hannula
VP, International Sales & Marketing
People
Jari Karhu
Medical Advisor
People
Jarmo Laine
VP, Medical Affairs
People
Mikko Karvinen
CEO

Unlock access to complete

Funding Insights of Nexstim

Nexstim has successfully raised a total of $29.67M across 7 strategic funding rounds. The most recent funding activity was a Debt – Conventional round of $1.22 million completed in January 2018. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 7
  • Last Round Debt – Conventional — $1.2M
  • First Round

    (06 Sep 2007)

  • Investors Count 8
Date Amount Transaction Name Valuation Lead Investors Investors
Jan, 2018 Amount Debt – Conventional - Nexstim Valuation

investors

Dec, 2017 Amount Debt – Venture - Nexstim Valuation

investors

Oct, 2017 Amount Post-IPO - Nexstim Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Nexstim

Nexstim has secured backing from 8 investors, including institutional and venture fund investors. Prominent investors backing the company include Kreos Capital, Life Sciences Partners and Capricorn Partners. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
Venture debt is provided to growth-stage companies across multiple sectors.
Founded Year Domain Location
Investments are directed by Capricorn Partners into European tech ventures.
Founded Year Domain Location
Private equity investments in life sciences businesses are managed.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Nexstim

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Nexstim

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Nexstim Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Nexstim

Nexstim operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Blackrock Neurotech, MindMaze, INBRAIN Neuroelectronics, Precision Neuroscience and Synergia Medical, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Medical devices for neurological therapies are developed.
domain founded_year HQ Location
Evidence-based digital neurotherapeutics are developed for brain health recovery.
domain founded_year HQ Location
AI-based neuroelectronic devices for brain disorder detection are developed.
domain founded_year HQ Location
Brain-computer interfaces developed for medical treatment and drug development.
domain founded_year HQ Location
Implantable neurostimulators and contactless monitoring systems are developed.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Nexstim

Frequently Asked Questions about Nexstim

When was Nexstim founded?

Nexstim was founded in 2000 and raised its 1st funding round 7 years after it was founded.

Where is Nexstim located?

Nexstim is headquartered in Helsinki, Finland.

Who is the current CEO of Nexstim?

Mikko Karvinen is the current CEO of Nexstim.

Is Nexstim a funded company?

Nexstim is a funded company, having raised a total of $29.67M across 7 funding rounds to date. The company's 1st funding round was a Post-IPO of $2.06M, raised on Sep 06, 2007.

How many employees does Nexstim have?

As of Dec 31, 2024, the latest employee count at Nexstim is 40.

What is the annual revenue of Nexstim?

Annual revenue of Nexstim is $9.08M as on Dec 31, 2024.

What does Nexstim do?

Nexstim was founded in 2000 in Helsinki, Finland, and operates within the medical technology sector. Noninvasive brain stimulation technologies are developed and supplied for the rehabilitation of stroke patients. Navigated Brain Stimulation (NBS), an image-guided transcranial magnetic stimulation system, is utilized for brain diagnostics and therapeutic applications. Services focus on clinical tools that support neurological recovery and assessment in healthcare settings across Europe and beyond.

Who are the top competitors of Nexstim?

Nexstim's top competitors include Blackrock Neurotech, Precision Neuroscience and INBRAIN Neuroelectronics.

What products or services does Nexstim offer?

Nexstim offers SmartFocus TMS, NBS System 5, and NBS System 6.

Is Nexstim publicly traded?

Yes, Nexstim is publicly traded on OMXHEX under the ticker symbol NXTMH.

Who are Nexstim's investors?

Nexstim has 8 investors. Key investors include Kreos Capital, Life Sciences Partners, Capricorn Partners, Business Finland, and City Financial Investment Company.

What is Nexstim's ticker symbol?

The ticker symbol of Nexstim is NXTMH on OMXHEX.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available